Answers are grounded in this paper and cite their sources.
Chromoblastomycosis (CBM) is a chronic implantation mycosis caused by melanized fungi and is often characterized by delayed diagnosis, long disease duration, and incomplete response to therapy.1,2 The diagnosis is usually established by direct microscopy, fungal culture, and histopathology; however, noninvasive imaging can provide rapid bedside clues and may help monitor treatment response over time.3-7 We report a case of long-standing CBM caused by Fonsecaea pedrosoi in which dermoscopy, reflectance confocal microscopy (RCM), and high-frequency ultrasound were used alongside conventional testing for diagnostic correlation and serial follow-up during combined therapy.
No takes yet. Share an insight, caveat, or question.
Nie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: